Cargando...
Pharmacokinetics, safety and tolerability of the novel β‐hCG derived immunomodulatory compound, EA‐230
AIMS: EA‐230 is a newly developed synthetic linear tetrapeptide (AQGV) derived from the chorionic gonadotropin hormone (β‐hCG). We investigated the pharmacokinetics, safety and tolerability of EA‐230 in healthy subjects using different administration strategies. METHODS: Double‐blind, randomized, pl...
Gardado en:
| Publicado en: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595371/ https://ncbi.nlm.nih.gov/pubmed/30924163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13942 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|